A proposed 10% tax rate for qualifying high-growth founders sits alongside a halving of Business Asset Disposal Relief. Eligibility, not the headline ceiling, will determine the effect.
AI conferences and digital acquisition solve different problems. Enterprise marketers should allocate budget according to trust, buyer complexity and target-account access.
Merck KGaA's proposed purchase of London-based Silence Therapeutics values its equity at $1.3 billion and highlights both the strength and funding pressures of Britain's clinical-stage biotech sector.
The competition regulator has not imposed new Microsoft software rules yet. Its 16 October proposal puts Copilot, security bundles and cloud licensing under scrutiny, with a decision due by February 2027.
An ONS survey finds record concern about energy and fuel prices. Hospitality and transport face different cost pressures, while supply-chain risks are spreading.
A four-year UKRI cluster commitment and new mayoral R&D powers move decisions closer to regions. The harder test is whether discoveries become durable businesses.
The government's response to the National Commission on AI in Healthcare aims to make approval, evidence and deployment more predictable. That could matter as much to UK AI companies as any new funding scheme.
Boards and senior leaders do not need to become engineers, but they increasingly need enough AI literacy to challenge assumptions, allocate capital and oversee risk.
Business research
Permanent reference coverage, company and location guides, and comparison-led research. News remains separately curated above.